AHIP Study Compares Claims Data with CDC Opioid Prescribing Guidelines
America’s Health Insurance Plans today released findings from a study assessing health insurance claims from 2009 to 2013 on six recommendations from the Centers for Disease Control and Prevention’s Guideline for Prescribing Opioids for Chronic Pain. According to AHIP, the vast majority of opioid prescriptions for chronic pain were for immediate-release opioids, consistent with CDC recommendations, but certain other measures could be improved. For example, about one-quarter of opioid prescriptions were above the CDC-recommended morphine milligram equivalent dosage, the organization said. The study methodology has been shared with insurance providers nationwide, who may apply it to measure their own opioid prevention and management efforts.
Related News Articles
Headline
The Department of Health and Human Services Office of Inspector General yesterday issued an alert warning of marketing schemes by certain Medicare Advantage…
Headline
The Office for Civil Rights in the Department of Health and Human Services Dec. 5 issued a letter to health care providers and others clarifying language…
Headline
The Congressional Budget Office Dec. 5 informed Congress that 2.2 million consumers would lose their health insurance in 2026 if enhanced premium subsidies are…
Perspective
December’s holiday rush is in full swing on Capitol Hill as Congress returned to Washington this week facing a long list of to-dos and a short time to do them…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
The Department of Health and Human Services' Government Accountability Office Nov. 14 released a report that determined the private health insurance market…